Novartis (Austria)
In research, Novartis (Austria) stands highest in Life Sciences (#4,489 of 14,347 worldwide), over all time.
- World rank, all time
- #10,018 of 42,892
- Rank in Austria
- #68 of 287
- Research works
- 358 ▲ 212% vs 2013–17
- Citations
- 19k 52.2 per fractional work
- Top-10% rate
- 11.5% record average 16.5%
- Open access
- 32% world 28%
What is Novartis (Austria) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Life SciencesDomain | #4,489 of 14,347 | 22.8% | 181 |
Each strip is that field’s whole ranked pool, with the notch where Novartis (Austria) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 13.3×. Every wedge is a field page.
- Veterinary 13.3×
- Decision Sciences 5.3×
- Biochemistry, Genetics and Molecular Biology 5.2×
- Immunology and Microbiology 5.0×
- Mathematics 3.3×
- Environmental Science 2.7×
- Health Professions 1.8×
- Medicine 0.9×
- Agricultural and Biological Sciences 0.9×
- Physics and Astronomy 0.8×
- Engineering 0.6×
- Business, Management and Accounting 0.6×
- Chemistry 0.5×
- Materials Science 0.4×
- Neuroscience 0.3×
- Economics, Econometrics and Finance 0.1×
Who are the top researchers at Novartis (Austria)?
Ranked on the composite score, Andreas Billich and Antal Rot lead among researchers whose main affiliation is Novartis (Austria).
- 1 Andreas Billich Austria · #182,341 worldwide 139 citations · 31 works
- 2 Antal Rot Austria · #698,850 worldwide 64 citations · 21 works
Which keywords describe research at Novartis (Austria)?
By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Cancer, Apoptosis, Glycosylation, Monoclonal Antibodies, Drug Discovery, Epidemiology and Therapeutic Antibodies.
- Membrane Proteins
- Tumor Antigen
- Antiretroviral Therapy
- Dendritic Cells
- Filaggrin
- Antigen Presentation
- Immune Responses
- Fc Receptors
- Cancer Therapy
- NK Cell Recognition
- Innate Immunity
- Foxp3
- Diagnosis
- Sphingolipids
- TGF-ß
- Transcriptional Regulation
- Therapeutic Antibodies
- Monoclonal Antibodies
- Apoptosis
- Cancer
- Inflammation
- Epidemiology
- Glycosylation
- Drug Discovery
- Angiogenesis
- Autoimmunity
- Insulin Resistance
- Sphingosine-1-Phosphate
- CD4+CD25+
- Immunity
- Antifungal Therapy
- Natural Killer Cells
- Antibody Engineering
- Immune Dysregulation
- Cancer Immunotherapy
- Staphylococcus aureus
- Skin Microbiome
- Signaling
- Extracellular Matrix
- Vaccine Adjuvants
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation46▲ 5.5×37 topics
- Cancer39▲ 7.7×28 topics
- Epidemiology30▲ 2.1×30 topics
- Apoptosis20▲ 14×8 topics
- Glycosylation17▲ 22×3 topics
- Monoclonal Antibodies17▲ 33×3 topics
- Drug Discovery16▲ 11×10 topics
- Therapeutic Antibodies15▲ 33×2 topics
- Angiogenesis15▲ 10×8 topics
- Transcriptional Regulation15▲ 16×6 topics
- Autoimmunity14▲ 19×5 topics
- TGF-ß14▲ 23×2 topics
- Insulin Resistance14▲ 8.3×4 topics
- Sphingolipids14▲ 282×1 topic
- Sphingosine-1-Phosphate14▲ 282×1 topic
- Diagnosis13▲ 3.6×11 topics
- CD4+CD25+13▲ 49×1 topic
- Foxp313▲ 49×1 topic
- Immunity12▲ 10×5 topics
- Innate Immunity12▲ 9.7×7 topics
- Antifungal Therapy11▲ 32×3 topics
- NK Cell Recognition11▲ 29×1 topic
- Natural Killer Cells11▲ 29×1 topic
- Cancer Therapy11▲ 4.7×11 topics
- Antibody Engineering10▲ 29×1 topic
- Fc Receptors10▲ 29×1 topic
- Immune Dysregulation10▲ 36×2 topics
- Immune Responses10▲ 29×3 topics
- Cancer Immunotherapy10▲ 20×3 topics
- Antigen Presentation10▲ 27×2 topics
- Staphylococcus aureus10▲ 36×2 topics
- Filaggrin9▲ 64×1 topic
- Skin Microbiome9▲ 64×1 topic
- Dendritic Cells9▲ 22×2 topics
- Signaling9▲ 22×4 topics
- Antiretroviral Therapy9▲ 11×5 topics
- Extracellular Matrix9▲ 10×5 topics
- Tumor Antigen9▲ 30×1 topic
- Vaccine Adjuvants9▲ 30×1 topic
- Membrane Proteins8▲ 13×3 topics
Which research topics does Novartis (Austria) publish most on?
By volume in 2022–2025: Viral Infectious Diseases and Gene Expression in Insects, Protein purification and stability, Safe Handling of Antineoplastic Drugs and Biosimilars and Bioanalytical Methods.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works
- 2 Protein purification and stability Molecular Biology 1 works
- 3 Safe Handling of Antineoplastic Drugs Occupational Therapy 0 works
- 4 Biosimilars and Bioanalytical Methods Immunology 0 works
- 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 6 Advanced Statistical Process Monitoring Statistics, Probability and Uncertainty 0 works
- 7 Constructed Wetlands for Wastewater Treatment Industrial and Manufacturing Engineering 0 works
- 8 Coastal wetland ecosystem dynamics Ecology 0 works
- 9 Bacterial Genetics and Biotechnology Genetics 0 works
- 10 Phosphorus and nutrient management Industrial and Manufacturing Engineering 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Novartis (Austria)'s research output changed?
Output in 2018–2022 was 212% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Vienna
- University of Vienna
- TU Wien
- Medical University of Vienna
- BOKU University
- Vienna University of Economics and Business
- Austrian Academy of Sciences
- University of Veterinary Medicine Vienna
- Austrian Institute of Technology
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.